Retail scripts of vaccines, acute drugs decline sharply amid COVID-19 pandemic It’s understandable that retail prescriptions of drugs have declined since COVID-19 hit the U.S., as patients refrain from visiting […]
AstraZeneca, Merck finally grab a green light for rare-disease med Koselugo It’s been a long road for AstraZeneca’s selumitinib, but one that’s finally led to a green light for the […]
Celgene nabs FDA approval for blockbuster hopeful anemia med Reblozyl Bristol-Myers Squibb’s $74 billion pending pick-up of Celgene has notched a win already with an FDA approval for JAK med […]
Pfizer’s ‘brainstorming’ payment deals as gene therapies advance, exec tells Bloomberg Gene therapies offer a “world of wonders” for patients, but they present some scientific and manufacturing challenges, a top […]
AbbVie unveils Venclexta data that scored lightning-fast leukemia combination nod Last month, partners AbbVie and Roche nabbed a speedy approval for Venclexta and Gazyva in chronic lymphocytic leukemia. And Tuesday, […]